(16648124), S. C., (16648127), C. C., (16648130), P. M., (15306139), D. D., (16648133), N. S., (14954757), E. d. S., . . . (14126577), T. S. (2025). Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways.
Chicago Style (17th ed.) Citation(16648124), Subhamoy Chakraborty, Charles Coleman (16648127), Parvathy Manoj (16648130), Deniz Demircioglu (15306139), Nisargbhai Shah (16648133), Elisa de Stanchina (14954757), Charles M. Rudin (11572933), Dan Hasson (15306151), and Triparna Sen (14126577). Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways. 2025.
MLA引文(16648124), Subhamoy Chakraborty, et al. Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways. 2025.